FDA Inspection
Carter BloodCare - RosedaleCarter BloodCare - Rosedale – FDA Inspection, Jan 16, 2019
Record Details
This FDA Inspection record concerns Carter BloodCare - Rosedale, with an inspection on January 16, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · aa052737-64fd-4b38-bb15-1adc6592e280
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1077022
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Carter BloodCare - Rosedale
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 8, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 5, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 23, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 18, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Carter BloodCare - Rosedale
- FDA Inspection 1243500 - 2024-06-27
- FDA Inspection 1006650 - 2017-02-08
- FDA Inspection 917722 - 2015-02-05
- FDA Inspection 845620 - 2013-08-23
- FDA Inspection 676470 - 2010-08-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.